Related Experiment Video
Updated: Jul 6, 2026

Production of Disulfide-stabilized Transmembrane Peptide Complexes for Structural Studies
Published on: March 6, 2013
Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor
1Protein Studies Program and Crystallography Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA.
Abstract:
Memapsin 2 (beta-secretase) is a membrane-associated aspartic protease involved in the production of beta-amyloid peptide in Alzheimer's disease and is a major target for drug design. We determined the crystal structure of the protease domain of human memapsin 2 complexed to an eight-residue inhibitor at 1.9 angstrom resolution. The active site of memapsin 2 is more open and less hydrophobic than that of other human aspartic proteases. The subsite locations from S4 to S2' are well defined. A kink of the inhibitor chain at P2' and the change of chain direction of P3' and P4' may be mimicked to provide inhibitor selectivity.
Insights
Memapsin 2, crucial in Alzheimer's disease, has a unique active site structure. This structural insight aids in designing selective inhibitors for potential Alzheimer's therapeutics.
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Memapsin 2 (beta-secretase) is a key enzyme in beta-amyloid peptide production, a hallmark of Alzheimer's disease.
- It is a significant target for developing therapeutic drugs to combat Alzheimer's disease.
Purpose of the Study:
- To determine the crystal structure of the protease domain of human memapsin 2.
- To analyze the structural characteristics of the memapsin 2 active site in complex with an inhibitor.
Main Methods:
- X-ray crystallography was used to determine the crystal structure.
- The structure was resolved at 1.9 angstrom resolution for the protease domain complexed with an eight-residue inhibitor.
Main Results:
- The active site of memapsin 2 exhibits a more open and less hydrophobic character compared to other human aspartic proteases.
- Specific subsite locations (S4 to S2') were clearly defined.
- An inhibitor kink at P2' and chain direction changes at P3'/P4' were observed.
Conclusions:
- The distinct structural features of the memapsin 2 active site offer opportunities for developing selective inhibitors.
- Understanding these structural details can guide the design of novel therapeutic agents targeting Alzheimer's disease.
More Related Videos
Related Concept Videos
Protein and Protein Structure
A protein's shape is critical to its function. For example, an enzyme can...
Ligand Binding and Linkage
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...

